[Microbiological method of determining cyanocobalamin in tissues and finished drugs made from animal raw materials]. 1983

Iu F Krylov, and B S Prokhorov

An assay for cyanocobalamin with the use of the test microorganism E. coli, mutant ATCC 9637, is offered. The measurement of the content of cyanocobalamin in the blood serum and liver of intact rats after intraperitoneal drug injection demonstrated its content to reach a maximum 30 minutes after injection and to depend on the dose. When given in doses 100 and 400 micrograms/kg, the drug dose in the serum amounted to 82 and 261 ng/g, respectively, and in the liver to 80 and 259 ng/g. The method is readily reproducible, does not require the observance of strict aseptics, it is economical and time-saving.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Iu F Krylov, and B S Prokhorov
January 1996, Developments in biological standardization,
Iu F Krylov, and B S Prokhorov
September 1995, Pharmaceutica acta Helvetiae,
Iu F Krylov, and B S Prokhorov
July 1986, Biulleten' eksperimental'noi biologii i meditsiny,
Iu F Krylov, and B S Prokhorov
August 1983, Bulletin of environmental contamination and toxicology,
Iu F Krylov, and B S Prokhorov
January 2001, Journal of AOAC International,
Iu F Krylov, and B S Prokhorov
November 1982, Analytical biochemistry,
Iu F Krylov, and B S Prokhorov
July 2000, The New England journal of medicine,
Iu F Krylov, and B S Prokhorov
June 1975, Journal of pharmaceutical sciences,
Copied contents to your clipboard!